| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | Canada | 4 | |
| #3 | Hong Kong | 4 | |
| #4 | United States | 3 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Climate change adaptation technologies | |
| #5 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zhou Zhiwen | 19 |
| #2 | Li Yuejuan | 15 |
| #3 | Feng Yuxia | 15 |
| #4 | Zuo Conglin | 15 |
| #5 | Fan Jundie | 4 |
| #6 | Jiang Lixin | 4 |
| Publication | Filing date | Title |
|---|---|---|
| WO2013139300A1 | Recombinant lentiviral vector formulation | |
| WO2012126369A1 | Dna, recombinant vector containing the same, cell, composition and use thereof | |
| US2006217326A1 | Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof |